Matthew Straesser is a Rheumatology/Immunology physician. OpenAlex indexes 18 publications with 299 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 S Logan Blvd Ste 3200
Hollidaysburg, PA 166483050
Telephone
814-944-2097Provider last certified this registry record 21 Sept 2020.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BioCryst US Sales Co., LLCProgram year20253 payments
- Cycle Pharmaceuticals IncProgram year20251 payment
- CSL BehringProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
98.3%Anti-IgE79.2%Omalizumab100%Part B, office-administered≥15 patientsCorticosteroid7.8%Fluticasone Propionate38%Trelegy Ellipta14%Breo Ellipta10%Dulera8%Budesonide-Formoterol Fumarate7%Mometasone Furoate7%Symbicort5%Breyna5%Arnuity Ellipta4%Fluticasone Propionate Hfa3%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
1.5%H2 blocker1.5%Famotidine100%Part D≥26 patientsDermatology
0.2%Interleukin-4 Receptor alpha Antagonist0.2%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency
Journal of Clinical Immunology
2023 - Quantitative Measurement of IgG to Severe Acute Respiratory Syndrome Coronavirus-2 Proteins Using ImmunoCAP
International Archives of Allergy and Immunology
2021 - Assigning Causality for Abnormal Tryptases: α-Gal and Other Causes of Anaphylaxis, Mastocytosis and More
Journal of Allergy and Clinical Immunology
2021 - Quantitative Measurement of IgG to SARS-CoV-2 Proteins Using the Phadia ImmunoCAP 250
Journal of Allergy and Clinical Immunology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”